Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: Proposed guidelines for improving data collection, distribution, and integration
Identifieur interne : 000538 ( Istex/Curation ); précédent : 000537; suivant : 000539Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: Proposed guidelines for improving data collection, distribution, and integration
Auteurs : M. Olivier [France] ; A. Petitjean [France] ; J. Teague [Royaume-Uni] ; S. Forbes [Royaume-Uni] ; J. K. Dunnick [États-Unis] ; J. T. Den Dunnen [Pays-Bas] ; A. Langer D [Norvège] ; J. M. Wilkinson [Royaume-Uni] ; M. Vihinen [Finlande, Australie] ; R. G. H. Cotton [Finlande] ; P. Hainaut [France]Source :
- Human Mutation [ 1059-7794 ] ; 2009-03.
English descriptors
Abstract
There are currently less than 40 locus‐specific databases (LSDBs) and one large general database that curate data on somatic mutations in human cancer genes. These databases have different scope and use different annotation standards and database systems, resulting in duplicated efforts in data curation, and making it difficult for users to find clear and consistent information. As data related to somatic mutations are generated at an increasing pace it is urgent to create a framework for improving the collecting of this information and making it more accessible to clinicians, scientists, and epidemiologists to facilitate research on biomarkers. Here we propose a data flow for improving the connectivity between existing databases and we provide practical guidelines for data reporting, database contents, and annotation standards. These proposals are based on common standards recommended by the Human Genome Variation Society (HGVS) with additions related to specific requirements of somatic mutations in cancer. Indeed, somatic mutations may be used in molecular pathology and clinical studies to characterize tumor types, help treatment choice, predict response to treatment and patient outcome, or in epidemiological studies as markers for tumor etiology or exposure assessment. Thus, specific annotations are required to cover these diverse research topics. This initiative is meant to promote collaboration and discussion on these issues and the development of adequate resources that would avoid the loss of extremely valuable information generated by years of basic and clinical research. Hum Mutat 0,1–8, 2008. © 2008 Wiley‐Liss, Inc.
Url:
DOI: 10.1002/humu.20832
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000538
Links to Exploration step
ISTEX:2DE84FF813197D14C9BAAE2548E4B68B956C6D42Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: Proposed guidelines for improving data collection, distribution, and integration</title><author><name sortKey="Olivier, M" sort="Olivier, M" uniqKey="Olivier M" first="M." last="Olivier">M. Olivier</name><affiliation wicri:level="1"><mods:affiliation>Group of Molecular Carcinogenesis and Biomarkers, International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Group of Molecular Carcinogenesis and Biomarkers, International Agency for Research on Cancer (IARC), World Health Organization, Lyon</wicri:regionArea></affiliation></author><author><name sortKey="Petitjean, A" sort="Petitjean, A" uniqKey="Petitjean A" first="A." last="Petitjean">A. Petitjean</name><affiliation wicri:level="1"><mods:affiliation>Group of Molecular Carcinogenesis and Biomarkers, International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Group of Molecular Carcinogenesis and Biomarkers, International Agency for Research on Cancer (IARC), World Health Organization, Lyon</wicri:regionArea></affiliation></author><author><name sortKey="Teague, J" sort="Teague, J" uniqKey="Teague J" first="J." last="Teague">J. Teague</name><affiliation wicri:level="1"><mods:affiliation>Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge</wicri:regionArea></affiliation></author><author><name sortKey="Forbes, S" sort="Forbes, S" uniqKey="Forbes S" first="S." last="Forbes">S. Forbes</name><affiliation wicri:level="1"><mods:affiliation>Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge</wicri:regionArea></affiliation></author><author><name sortKey="Dunnick, J K" sort="Dunnick, J K" uniqKey="Dunnick J" first="J. K." last="Dunnick">J. K. Dunnick</name><affiliation wicri:level="2"><mods:affiliation>Toxicology Operations Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina</mods:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Caroline du Nord</region></placeName><wicri:cityArea>Toxicology Operations Branch, National Institute of Environmental Health Sciences, Research Triangle Park</wicri:cityArea></affiliation></author><author><name sortKey="Den Dunnen, J T" sort="Den Dunnen, J T" uniqKey="Den Dunnen J" first="J. T." last="Den Dunnen">J. T. Den Dunnen</name><affiliation wicri:level="1"><mods:affiliation>Leiden University Medical Center, Leiden, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Leiden University Medical Center, Leiden</wicri:regionArea></affiliation></author><author><name sortKey="Langer D, A" sort="Langer D, A" uniqKey="Langer D A" first="A." last="Langer D">A. Langer D</name><affiliation wicri:level="1"><mods:affiliation>Department of Genetics, Institute for Cancer Research, Rikshospitalet‐Radiumhospitalet Medical Center, Oslo, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Genetics, Institute for Cancer Research, Rikshospitalet‐Radiumhospitalet Medical Center, Oslo</wicri:regionArea></affiliation></author><author><name sortKey="Wilkinson, J M" sort="Wilkinson, J M" uniqKey="Wilkinson J" first="J. M." last="Wilkinson">J. M. Wilkinson</name><affiliation wicri:level="1"><mods:affiliation>National Cancer Research Institute (NCRI) Cancer Informatics Initiative, London, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>National Cancer Research Institute (NCRI) Cancer Informatics Initiative, London</wicri:regionArea></affiliation></author><author><name sortKey="Vihinen, M" sort="Vihinen, M" uniqKey="Vihinen M" first="M." last="Vihinen">M. Vihinen</name><affiliation wicri:level="1"><mods:affiliation>Institute of Medical Technology, University of Tampere, Finland</mods:affiliation><country xml:lang="fr">Finlande</country><wicri:regionArea>Institute of Medical Technology, University of Tampere</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Genomic Disorders Research Centre, St. Vincent's Hospital Melbourne, Melbourne, Australia</mods:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Genomic Disorders Research Centre, St. Vincent's Hospital Melbourne, Melbourne</wicri:regionArea></affiliation></author><author><name sortKey="Cotton, R G H" sort="Cotton, R G H" uniqKey="Cotton R" first="R. G. H." last="Cotton">R. G. H. Cotton</name><affiliation wicri:level="1"><mods:affiliation>Tampere University Hospital, Tampere, Finland</mods:affiliation><country xml:lang="fr">Finlande</country><wicri:regionArea>Tampere University Hospital, Tampere</wicri:regionArea></affiliation></author><author><name sortKey="Hainaut, P" sort="Hainaut, P" uniqKey="Hainaut P" first="P." last="Hainaut">P. Hainaut</name><affiliation wicri:level="1"><mods:affiliation>Group of Molecular Carcinogenesis and Biomarkers, International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Group of Molecular Carcinogenesis and Biomarkers, International Agency for Research on Cancer (IARC), World Health Organization, Lyon</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:2DE84FF813197D14C9BAAE2548E4B68B956C6D42</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1002/humu.20832</idno><idno type="url">https://api.istex.fr/document/2DE84FF813197D14C9BAAE2548E4B68B956C6D42/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000538</idno><idno type="wicri:Area/Istex/Curation">000538</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: Proposed guidelines for improving data collection, distribution, and integration</title><author><name sortKey="Olivier, M" sort="Olivier, M" uniqKey="Olivier M" first="M." last="Olivier">M. Olivier</name><affiliation wicri:level="1"><mods:affiliation>Group of Molecular Carcinogenesis and Biomarkers, International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Group of Molecular Carcinogenesis and Biomarkers, International Agency for Research on Cancer (IARC), World Health Organization, Lyon</wicri:regionArea></affiliation></author><author><name sortKey="Petitjean, A" sort="Petitjean, A" uniqKey="Petitjean A" first="A." last="Petitjean">A. Petitjean</name><affiliation wicri:level="1"><mods:affiliation>Group of Molecular Carcinogenesis and Biomarkers, International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Group of Molecular Carcinogenesis and Biomarkers, International Agency for Research on Cancer (IARC), World Health Organization, Lyon</wicri:regionArea></affiliation></author><author><name sortKey="Teague, J" sort="Teague, J" uniqKey="Teague J" first="J." last="Teague">J. Teague</name><affiliation wicri:level="1"><mods:affiliation>Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge</wicri:regionArea></affiliation></author><author><name sortKey="Forbes, S" sort="Forbes, S" uniqKey="Forbes S" first="S." last="Forbes">S. Forbes</name><affiliation wicri:level="1"><mods:affiliation>Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge</wicri:regionArea></affiliation></author><author><name sortKey="Dunnick, J K" sort="Dunnick, J K" uniqKey="Dunnick J" first="J. K." last="Dunnick">J. K. Dunnick</name><affiliation wicri:level="2"><mods:affiliation>Toxicology Operations Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina</mods:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Caroline du Nord</region></placeName><wicri:cityArea>Toxicology Operations Branch, National Institute of Environmental Health Sciences, Research Triangle Park</wicri:cityArea></affiliation></author><author><name sortKey="Den Dunnen, J T" sort="Den Dunnen, J T" uniqKey="Den Dunnen J" first="J. T." last="Den Dunnen">J. T. Den Dunnen</name><affiliation wicri:level="1"><mods:affiliation>Leiden University Medical Center, Leiden, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Leiden University Medical Center, Leiden</wicri:regionArea></affiliation></author><author><name sortKey="Langer D, A" sort="Langer D, A" uniqKey="Langer D A" first="A." last="Langer D">A. Langer D</name><affiliation wicri:level="1"><mods:affiliation>Department of Genetics, Institute for Cancer Research, Rikshospitalet‐Radiumhospitalet Medical Center, Oslo, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Genetics, Institute for Cancer Research, Rikshospitalet‐Radiumhospitalet Medical Center, Oslo</wicri:regionArea></affiliation></author><author><name sortKey="Wilkinson, J M" sort="Wilkinson, J M" uniqKey="Wilkinson J" first="J. M." last="Wilkinson">J. M. Wilkinson</name><affiliation wicri:level="1"><mods:affiliation>National Cancer Research Institute (NCRI) Cancer Informatics Initiative, London, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>National Cancer Research Institute (NCRI) Cancer Informatics Initiative, London</wicri:regionArea></affiliation></author><author><name sortKey="Vihinen, M" sort="Vihinen, M" uniqKey="Vihinen M" first="M." last="Vihinen">M. Vihinen</name><affiliation wicri:level="1"><mods:affiliation>Institute of Medical Technology, University of Tampere, Finland</mods:affiliation><country xml:lang="fr">Finlande</country><wicri:regionArea>Institute of Medical Technology, University of Tampere</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Genomic Disorders Research Centre, St. Vincent's Hospital Melbourne, Melbourne, Australia</mods:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Genomic Disorders Research Centre, St. Vincent's Hospital Melbourne, Melbourne</wicri:regionArea></affiliation></author><author><name sortKey="Cotton, R G H" sort="Cotton, R G H" uniqKey="Cotton R" first="R. G. H." last="Cotton">R. G. H. Cotton</name><affiliation wicri:level="1"><mods:affiliation>Tampere University Hospital, Tampere, Finland</mods:affiliation><country xml:lang="fr">Finlande</country><wicri:regionArea>Tampere University Hospital, Tampere</wicri:regionArea></affiliation></author><author><name sortKey="Hainaut, P" sort="Hainaut, P" uniqKey="Hainaut P" first="P." last="Hainaut">P. Hainaut</name><affiliation wicri:level="1"><mods:affiliation>Group of Molecular Carcinogenesis and Biomarkers, International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Group of Molecular Carcinogenesis and Biomarkers, International Agency for Research on Cancer (IARC), World Health Organization, Lyon</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Human Mutation</title><title level="j" type="abbrev">Hum. Mutat.</title><idno type="ISSN">1059-7794</idno><idno type="eISSN">1098-1004</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2009-03">2009-03</date><biblScope unit="volume">30</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="275">275</biblScope><biblScope unit="page" to="282">282</biblScope></imprint><idno type="ISSN">1059-7794</idno></series><idno type="istex">2DE84FF813197D14C9BAAE2548E4B68B956C6D42</idno><idno type="DOI">10.1002/humu.20832</idno><idno type="ArticleID">HUMU20832</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1059-7794</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>somatic mutation; database; standards</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">There are currently less than 40 locus‐specific databases (LSDBs) and one large general database that curate data on somatic mutations in human cancer genes. These databases have different scope and use different annotation standards and database systems, resulting in duplicated efforts in data curation, and making it difficult for users to find clear and consistent information. As data related to somatic mutations are generated at an increasing pace it is urgent to create a framework for improving the collecting of this information and making it more accessible to clinicians, scientists, and epidemiologists to facilitate research on biomarkers. Here we propose a data flow for improving the connectivity between existing databases and we provide practical guidelines for data reporting, database contents, and annotation standards. These proposals are based on common standards recommended by the Human Genome Variation Society (HGVS) with additions related to specific requirements of somatic mutations in cancer. Indeed, somatic mutations may be used in molecular pathology and clinical studies to characterize tumor types, help treatment choice, predict response to treatment and patient outcome, or in epidemiological studies as markers for tumor etiology or exposure assessment. Thus, specific annotations are required to cover these diverse research topics. This initiative is meant to promote collaboration and discussion on these issues and the development of adequate resources that would avoid the loss of extremely valuable information generated by years of basic and clinical research. Hum Mutat 0,1–8, 2008. © 2008 Wiley‐Liss, Inc.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/CyberinfraV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000538 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000538 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Ticri/CIDE
|area= CyberinfraV1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:2DE84FF813197D14C9BAAE2548E4B68B956C6D42
|texte= Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: Proposed guidelines for improving data collection, distribution, and integration
}}
| This area was generated with Dilib version V0.6.25. |  |